撤回：大麻素WIN 55,212-2通过触发ROS介导的信号通路抑制人胶质瘤细胞生长。
Retracted: Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
作者信息
International BioMed Research
出版信息
Biomed Res Int. 2023 Jul 12;2023:9803081. doi: 10.1155/2023/9803081. eCollection 2023.
Abstract
[This retracts the article DOI: 10.1155/2021/6612592.].
摘要
[本文撤回文章DOI: 10.1155/2021/6612592。]
相似文献
1
Retracted: Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Biomed Res Int. 2023 Jul 12;2023:9803081. doi: 10.1155/2023/9803081. eCollection 2023.
2
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Biomed Res Int. 2021 Apr 22;2021:6612592. doi: 10.1155/2021/6612592. eCollection 2021.
3
Retracted: TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma through Modulating AKT Signaling.
J Oncol. 2023 Jan 23;2023:9767535. doi: 10.1155/2023/9767535. eCollection 2023.
4
Cannabinoid WIN 55,212-2 induces cell cycle arrest and apoptosis, and inhibits proliferation, migration, invasion, and tumor growth in prostate cancer in a cannabinoid-receptor 2 dependent manner.
Prostate. 2019 Feb;79(2):151-159. doi: 10.1002/pros.23720. Epub 2018 Sep 21.
5
Retracted: Peptide ARHGEF9 Inhibits Glioma Progression via PI3K/AKT/mTOR Pathway.
Dis Markers. 2023 Aug 9;2023:9849123. doi: 10.1155/2023/9849123. eCollection 2023.
6
[Retracted] miR‑218 inhibits the migration and invasion of glioma U87 cells through the Slit2‑Robo1 pathway.
Oncol Lett. 2023 Sep 25;26(5):481. doi: 10.3892/ol.2023.14068. eCollection 2023 Nov.
7
[Retracted] Inhibition of δ‑opioid receptors induces brain glioma cell apoptosis through the mitochondrial and protein kinase C pathways.
Oncol Lett. 2023 Mar 20;25(5):182. doi: 10.3892/ol.2023.13768. eCollection 2023 May.
8
The synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent manner.
J Biol Chem. 2005 Oct 28;280(43):35797-806. doi: 10.1074/jbc.M507959200. Epub 2005 Aug 16.
9
Involvement of the CB cannabinoid receptor in cell growth inhibition and G0/G1 cell cycle arrest via the cannabinoid agonist WIN 55,212-2 in renal cell carcinoma.
BMC Cancer. 2018 May 23;18(1):583. doi: 10.1186/s12885-018-4496-1.
10
[Retracted] RNA interference‑mediated USP22 gene silencing promotes human brain glioma apoptosis and induces cell cycle arrest.
Oncol Lett. 2023 Mar 13;25(4):170. doi: 10.3892/ol.2023.13756. eCollection 2023 Apr.
本文引用的文献
1
Cannabinoid WIN 55,212-2 Inhibits Human Glioma Cell Growth by Triggering ROS-Mediated Signal Pathways.
Biomed Res Int. 2021 Apr 22;2021:6612592. doi: 10.1155/2021/6612592. eCollection 2021.
Zotero 插件